Abstract
Purpose of reviewIdiopathic inflammatory myopathies (IIM) are rare diseases with heterogenous clinicopathological features. In recent years, new classification systems considering various combinations of clinical, serological, and pathological information have been proposed. This review summarizes recent clinicoseropathological development in major subgroups of IIM.Recent findingsConsidering clinicoseropathological features, IIM are suggestively classified into four major subgroups: dermatomyositis, immune-mediated necrotizing myopathy (IMNM), antisynthetase syndrome (ASS), and inclusion body myositis (IBM). Many historically diagnosed polymyositis have been mainly reclassified as IBM, IMNM, and ASS. Different types of myositis-specific antibodies (MSA) suggest distinct clinicopathological subsets of IIM. Excluding IBM, at least one-Third of the IIMs have no known associated MSA.SummaryMSA are crucial for IIM classification but can be negative. Thus, IIM should be universally classified using stepwise or integrated information on clinical, serological, and pathological findings.
| Original language | English |
|---|---|
| Pages (from-to) | 704-714 |
| Number of pages | 11 |
| Journal | Current Opinion in Neurology |
| Volume | 32 |
| Issue number | 5 |
| DOIs | |
| Publication status | Published - 1 Oct 2019 |
| Externally published | Yes |
Keywords
- antisynthetase syndrome
- dermatomyositis
- immune-mediated necrotizing myopathy
- inclusion body myositis
- myositis-specific antibody
Fingerprint
Dive into the research topics of 'Classification of idiopathic inflammatory myopathies: Pathology perspectives'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver